trastuzumab

You have access
Prognostic Significance of HER2 Expression for Gastric Cancer With Clinically Para-aortic Lymph Node Metastasis
TAKAAKI ARIGAMI, DAISUKE MATSUSHITA, KEISHI OKUBO, KEN SASAKI, YUSUKE TSURUDA, YOSHIAKI KITA, SHINICHIRO MORI, SHIGEHIRO YANAGITA, YOSHIKAZU UENOSONO, HIROSHI KURAHARA and TAKAO OHTSUKA

Anticancer Research June 2021, 41 (6) 3099-3107; DOI: https://doi.org/10.21873/anticanres.15094
You have access
Evaluation of the Role of p95 HER2 Isoform in Trastuzumab Efficacy in Metastatic Breast Cancer
GEORGIOS RIGAKOS, EVANGELIA RAZIS, GEORGIA-ANGELIKI KOLIOU, GEORGIOS OIKONOMOPOULOS, ELEFTHERIA TSOLAKI, JEFF SPERINDE, SOFIA CHRISAFI, GEORGE ZARKAVELIS, ELISSAVET PAZARLI, ANNA BATISTATOU, HELEN P. KOUREA, PAVLOS PAPAKOSTAS, DIMITRIOS BAFALOUKOS, NATALIA I. ASIMAKOPOULOU, ELENI RES, ATHANASIOS KOTSAKIS, DIMITRIOS PECTASIDES, ANGELOS KOUTRAS, CHRISTOS CHRISTODOULOU and GEORGE FOUNTZILAS

Anticancer Research April 2021, 41 (4) 1793-1802; DOI: https://doi.org/10.21873/anticanres.14945
You have access
Resumption of Trastuzumab in Patients With Disease Recurrence After (Neo-) Adjuvant Anti-HER2-therapy in Patients With HER2-positive Breast Cancer
LARS CHRISTIAN HANKER, FRANK FÖRSTER, JAN SCHRÖDER, ANDREA GRAFE, THOMAS HITSCHOLD, TOBIAS HESSE, CLAUS RICHARD LATTRICH and ACHIM RODY

Anticancer Research July 2020, 40 (7) 3973-3981; DOI: https://doi.org/10.21873/anticanres.14390
You have access
Low Eosinophil Percentages as a New Predictive Marker for Infusion Reactions Due to Trastuzumab
MASAYA TAKAHASHI, KATSUYUKI TAKAHASHI, SAYA MATSUMOTO, TSUTOMU TAKASHIMA, YUKA ASANO, TAMAMI MORISAKI, SHINICHIRO KASHIWAGI, SATORU NODA, NAOYOSHI ONODA, MASAICHI OHIRA and KATSUYA NAGAYAMA

Anticancer Research July 2020, 40 (7) 4047-4051; DOI: https://doi.org/10.21873/anticanres.14401
You have access
Efficacy of Adjuvant Combination Therapy With Trastuzumab and Chemotherapy in HER2-positive Early Breast Cancer: A Single Institutional Cohort Study from Clinical Practice
MASAHIRO OKAMOTO, WAKAKO TAJIRI, HIROKI UEO, TAKANOBU MASUDA, HIDEKI IJICHI, CHINAMI KOGA, YOSHIAKI NAKAMURA, KENICHI TAGUCHI, SHINJI OHNO and ERIKO TOKUNAGA

Anticancer Research June 2020, 40 (6) 3315-3323; DOI: https://doi.org/10.21873/anticanres.14314
You have access
Role of FOXO3A in Trastuzumab Combination Chemotherapy in Esophageal Squamous Cell Carcinoma
MASASHI TAKAHASHI, KAZUMASA FUKUDA, YOSHIRO SAIKAWA, RIEKO NAKAMURA, NORIHITO WADA, HIROFUMI KAWAKUBO, HIROYA TAKEUCHI and YUKO KITAGAWA

Anticancer Research April 2020, 40 (4) 1921-1930; DOI: https://doi.org/10.21873/anticanres.14147
You have access
Comparison of HER2 Status Before and After Trastuzumab-based Chemotherapy in Patients With Advanced Gastric Cancer
TAKASHI KIJIMA, TAKAAKI ARIGAMI, YOSHIKAZU UENOSONO, TSUBASA HIRAKI, SHIGEHIRO YANAGITA, DAISUKE MATSUSHITA, KEISHI OKUBO, MASATAKA SHIMONOSONO, SUMIYA ISHIGAMI, KOSEI MAEMURA, AKIHIDE TANIMOTO and SHOJI NATSUGOE

Anticancer Research January 2020, 40 (1) 75-80; DOI: https://doi.org/10.21873/anticanres.13927
You have access
Cardiovascular Risk Factors and Timing of Anthracyclines and Trastuzumab Cardiac Toxicity
MARIA LAURA CANALE, ANDREA CAMERINI, ALDA HUQI, ALESSIO LILLI, IRMA BISCEGLIA, IRIS PARRINI, CHIARA LESTUZZI, JACOPO DEL MEGLIO, SARA DONATI, ELIO VENTURINI, ALESSANDRO SGAMBATO, LUIGI TARANTINI, DOMENICO AMOROSO and GIANCARLO CASOLO

Anticancer Research October 2019, 39 (10) 5741-5745; DOI: https://doi.org/10.21873/anticanres.13775
You have access
The Economic Impact of Biosimilars in Oncology and Hematology: The Case of Trastuzumab and Rituximab
JACOPO GIULIANI and ANDREA BONETTI

Anticancer Research July 2019, 39 (7) 3971-3973; DOI: https://doi.org/10.21873/anticanres.13552
You have access
Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Trastuzumab Followed by 5-Fluorouracil/Epirubicin/Cyclophosphamide for HER2-positive Operable Breast Cancer: A Multicenter Phase II Trial
SHINYA TOKUNAGA, TSUTOMU TAKASHIMA, SHINICHIRO KASHIWAGI, SATORU NODA, HIDEMI KAWAJIRI, MAO TOKUMOTO, SHIGEHIKO NISHIMURA, TAKEO NISHIMORI, KATSUMI IKEDA, YOSHINARI OGAWA, YOKO MIZUYAMA, TAKESHI SUNAMI, KENJI TEZUKA, SHIGEHITO YAMAGATA, TETSURO ISHIKAWA, SHINZOH KUDOH, MINORU TAKADA, KOSEI HIRAKAWA and MASAICHI OHIRA

Anticancer Research April 2019, 39 (4) 2053-2059; DOI: https://doi.org/10.21873/anticanres.13316

Main menu

User menu

Search

trastuzumab

Pages